- This event has passed.
Prioritising genomic medicine: reflections on the role of health economics for changing policy and clinical practice
September 6, 2022 @ 6:00 pm - 8:15 pm EDT
Genomic medicine is rapidly changing the healthcare paradigm for multiple conditions, including cancer and rare diseases. With governments around the world increasingly investing in genomics research and implementation into clinical practice, and with the health economics evidence base on genomic medicine expanding, it is important to reflect on the role of health economics to change policy and clinical practice for genomic medicine.
Against this background, we are pleased to present the first symposium of the Economics of Genomics and Precision Medicine (Econ-Omics) SIG. The symposium will take place online between 1800-2015 EST on Tuesday 6th September and will consist of the following:
- an introduction (1800-1810)
- a panel discussion (1810-1925)
- a short break (1925-1930)
- then a workshop (1930-2015)
The symposium will begin by bringing together four experts for a panel discussion centred on the symposium title. The panelists are all specialists in health economics and genomics who will reflect on their experiences when generating health economic evidence across multiple jurisdictions for prioritising genomic medicine. Panelists will outline key challenges, critical elements for success when undertaking research in this space, and visions for the future.
A particular challenge is how to encourage and facilitate international collaborations going forward in this research space. The panel discussion will therefore be followed by a facilitated discussion in a workshop setting with early career researchers and researchers from low- and middle-income countries. The aim of this workshop is to ensure that the SIG takes forward high value activities for supporting capacity building in health economics of genomic medicine.
The Symposium will be facilitated by the conveners of the SIG. The four panelists will be:
- Scott Grosse, Centers for Disease Control and Prevention, USA
- Sarah Norris, Associate Professor, University of Sydney, Australia
- Li Yang, Associate Professor, Peking University, China
- Brock Schroeder, Vice President, Market Access, Illumina Inc., USA